0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > Kits > FGF basic > CEA-C082

ClinMax™ Human bFGF/FGF2 ELISA Kit

For research use only.

Order Now

    Product Details
    ClinMax™ Human bFGF/FGF2 ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human FGF basic/FGF2/bFGF that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:
    1. Standards to calibrate with NIBSC/WHO standards for comparable results.
    2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.
  • Application

    The kit is developed for quantitative detection of natural and recombinant human FGF basic/FGF2/bFGF in serum, plasma and cell culture supernatants.

    It is for research use only.

  • Workflow
     FGF basic Workflow
    Key Features
    AnalytebFGF/FGF2
    Assay TypeSandwich-ELISA
    ReactivityHuman
    Sensitivity7 pg/ml
    Range10.94 pg/mL-700 pg/mL
    Assay Time2.75 hr
    Sample TypeCell Culture Supernatants, Plasma, Serum.
    Sample volume50 uL
    Format96-wells plate breakable into 12 x 8 wells strips

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Storage
    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Typical Data Please refer to DS document for the assay protocol.
 FGF basic TYPICAL DATA

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of bFGF/FGF2 is less than 7 pg/mL.

Validation
Intra-Assay Statistics

Ten replicates of each of 3 samples containing different bFGF/FGF2 concentrations were tested in one assay. Acceptable criteria: CV<10%.

 FGF basic INTRA-ASSAY STATISTICS
Inter-Assay Statistics

3 samples containing different concentrations of bFGF/FGF2 were tested in independent assays. Acceptable criteria: CV<15%.

 FGF basic INTER-ASSAY STATISTICS
Recovery

Recombinant bFGF/FGF2 was spiked into 3 human serum samples, and then analyzed. The average recovery of bFGF/FGF2 for serum samples is 100.9%.

 FGF basic RECOVERY
Materials Provided
IDComponentsSize
CEA082-C01Pre-coated Anti-bFGF/FGF2 Antibody Microplate1 plate
CEA082-C02Human bFGF/FGF2 Standard20μg ×2
CEA082-C03Biotin-Anti-bFGF/FGF2 Antibody Con. Solution100 μL
CEA082-C04Biotin-Antibody Dilution Buffer8 mL
CEA082-C05Streptavidin-HRP Con. Solution500 uL
CEA082-C06Streptavidin-HRP Dilution Buffer15 mL
CEA082-C0720× Washing Buffer50 mL
CEA082-C08Sample Dilution Buffer15 mL ×2
CEA082-C09Substrate Solution12 mL
CEA082-C10Stop Solution6 mL
  • Clinical and Translational Updates

Comments (0)


Voraussichtlicher Liefertermin für vorrätige Produkte: 2 Arbeitstage

Price(EUR) : €500.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:1 Details
  • Number of Drugs in Clinical Trials:3 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Nachricht schicken